SYR-322_309 PADALon: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared With Placebo in Pediatric Subjects With Type 2Diabetes Mellitus

Project: Research project

Project Details

StatusFinished
Effective start/end date12/19/18 → 10/31/21

Funding

  • The EMMES Corporation
  • Takeda Pharmaceuticals